BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee MH, Kim BJ. COVID-19 vaccine development based on recombinant viral and bacterial vector systems: combinatorial effect of adaptive and trained immunity. J Microbiol 2022;60:321-34. [PMID: 35157221 DOI: 10.1007/s12275-022-1621-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Bandi C, Mendoza-Roldan JA, Otranto D, Alvaro A, Louzada-Flores VN, Pajoro M, Varotto-Boccazzi I, Brilli M, Manenti A, Montomoli E, Zuccotti G, Epis S. Leishmania tarentolae: a vaccine platform to target dendritic cells and a surrogate pathogen for next generation vaccine research in leishmaniases and viral infections. Parasit Vectors 2023;16:35. [PMID: 36703216 DOI: 10.1186/s13071-023-05651-1] [Reference Citation Analysis]
2 Totolian AA, Smirnov VS, Krasnov AA, Ramsay ES, Dedkov VG, Popova AY. COVID-19 Case Numbers as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type.. [DOI: 10.21203/rs.3.rs-2183670/v1] [Reference Citation Analysis]
3 Gong W, An H, Wang J, Cheng P, Qi Y. The Natural Effect of BCG Vaccination on COVID-19: The Debate Continues. Front Immunol 2022;13:953228. [DOI: 10.3389/fimmu.2022.953228] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Myoung J. Two years of COVID-19 pandemic: where are we now? J Microbiol 2022;60:235-7. [PMID: 35235176 DOI: 10.1007/s12275-022-1679-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]